REASSURE AV Registry

NACompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Sudden Cardiac DeathBradycardia
Interventions
DEVICE

AV Therapy Assessment-B301 investigational device

Atrial and ventricular tachyarrhythmia therapy delivered by the B301 investigational device

Trial Locations (36)

Unknown

Alaska Heart Institute, Anchorage

Northern California Heart Care, Larkspur

Orlando Regional Hospital, Orlando

Heart and Vascular Institute, St. Petersburg

Piedmont Hospital, Atlanta

St. Joseph Hospital, Savannah

Good Samaritan Hospital, Downers Grove

Heart Care Research Foundation, Merrionette Park

St. Mary Medical Center, Hobart

Mercy Hospital Medical Center, Des Moines

Central Baptist Hospital, Lexington

Louisville Cardiology Medical Group, Louisville

Medical Center Cardiologist Research, Louisville

Owensboro Mercy Health System, Owensboro

Ochsner Foundation Hospital, New Orleans

Boston Medical Center, Boston

Lahey Clinic Medical Center, Burlington

Baystate Medical Center, Springfield

University of Massachusetts, Worcester

Henry Ford Hospital, Detroit

Saint Mary's Duluth Clinic, Duluth

St. Anthony's Medical Center, St Louis

Sunrise Hospital & Medical Center, Las Vegas

Deborah Heart and Lung Center, Browns Mills

Mount Sinai Medical Center, New York

Christ Hospital - Cincinnati, Cincinnati

The Cleveland Clinic Foundation, Cleveland

Ohio State University Medical Center, Columbus

Hillcrest Medical Center, Tulsa

Abington Memorial Hospital, Abington

Reading Hospital and Medical Center, West Reading

Baylor University Medical Center, Dallas

Center For Cardiac Arrhythmias, Houston

Inova Fairfax Hospital, Fairfax

Sentara Norfolk General Hospital, Norfolk

Chippenham Medical Center, Richmond

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY